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Sheehan et al (2002) published a paper on UV-dimers
in human skin and their repair with contradictions in
their own data. In one experiment they applied two
doses, 0.65 and 2 MED, but the apparent dimer
levels, measured by a immunohistochemical tech-
nique, only increased in skin of type II (Fig 2a). The
authors offered as explanation that the level of DNA
damage would saturate. The dimer levels reached are
at around 1 dimer per 1 million nucleotides, and
there has been no evidence for saturation when a
quantitative postlabeling technique has been used
(Bykov et al, 1998). There is no reason for saturation
until most of the thydmidyl-thymidine positions
would be occupied in DNA, which, based on litera-
ture with other intrastrand cross-linkers, would
require dimer levels 1 : 100 (FoÈrsti et al, 1989), or
10,000 times higher levels of dimer than that
obtained by an irradiation at a MED dose.
I
n the paper, the authors applied repeated doses of UV to
skin. It is instructive to consider the expected results in such
an experiment, if repair did not take place at all, or if it was
very fast. If there is no DNA repair, repeated doses cause an
accumulation of damage, 10 doses giving 10 times more
dimer than 1 dose. If, on the other hand, DNA repair works fast
and there is no accumulation of dimers, as was the case in this study
(exactly same dimer levels in their Fig 2a,b), repair has to remove
within 24 h day all dimers produced in the previous day. The same
levels of dimers after a single dose and 10 repeated doses in Fig 2
show that repair is working ef®ciently in both skin type groups, i.e.
all dimers produced in one day are removed by the next day. The
authors then make a separate repair test and take a sample 1 week
after the last UV dose. Why they choose 1 week and not some
hours for repair time remains unexplained, because their own
experiment showed that 100% of dimers were removed in 1 day.
With such a rapid repair no dimers should be found after 1 week,
but surprisingly, the authors believe that substantial dimer levels
remain (Fig 3). The data in Fig 2 fully contradict those in Fig 3.
Most likely, the apparent dimer remaining after 1 week of repair is
in fact some nonspeci®c background, as dimers were already
removed during the ®rst day.
Sheehan and Young have been coauthors in an uncited paper
where kinetics of dimer removal were measured by a quantitative
technique, and 50% of TT dimer was removed in 17 h (Bykov et al,
1999). These results have been repeated in many studies (Zhao et al
2002). Because not all dimer is removed in 24 h, repeated
exposures cause some accumulation of damage, as we have
shown in another uncited paper (Xu et al 2001). We have also
shown recently by a quantitative technique that dimer levels are
about 2 times higher in skin of persons with skin type I compared
to persons with skin type IV after a uniform dose (Hemminki et al
2002), as would be expected, but opposite to the data of Sheehan et
al (2002). In that paper we also showed that some 2±9% of the
initial TT dimer was detected 3 weeks after exposure.
One may thus wonder what the problem has been? Neither
DNA antibodies nor immunohistochemistry is a quantitative tool
to measure DNA damage. There are old warnings that they are not
even qualitative tools (Fichtinger-Schepman et al, 1989). In the
Sheehan et al (2002) paper there is yet another warning.
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